Autoimmune Disease Diagnostics Market by Type (Localized Autoimmune Disease Diagnostics, Systemic Autoimmune Disease Diagnostics), Indication (Addison Disease, Celiac Disease, Dermatomyositis), Test, Product, End User - Global Forecast 2024-2030
The Autoimmune Disease Diagnostics Market size was estimated at USD 5.08 billion in 2023 and expected to reach USD 5.53 billion in 2024, at a CAGR 9.06% to reach USD 9.33 billion by 2030.
FPNV Positioning Matrix
The FPNV Positioning Matrix is pivotal in evaluating the Autoimmune Disease Diagnostics Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).
Market Share Analysis
The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Autoimmune Disease Diagnostics Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.
Key Company Profiles
The report delves into recent significant developments in the Autoimmune Disease Diagnostics Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, AESKU.GROUP GmbH & Co. KG, AstraZeneca PLC, Beckman Coulter, Inc., Bio-Rad Laboratories, Inc., BioAgilytix Labs, Biogenuix Medsystems Private Limited, bioMerieux SA, EUROIMMUN Medical Laboratory Diagnostics AG, Exagen Inc., F. Hoffmann-La Roche AG, Hemagen Diagnostics, Inc., Novartis AG, Pfizer Inc., Quest Diagnostics, Sanofi S.A., SD BioSensor Inc., Siemens Healthineers AG, SQI Diagnostics, Thermo Fisher Scientific Inc., Trinity Biotech PLC, and Werfen Group.
Market Segmentation & Coverage
This research report categorizes the Autoimmune Disease Diagnostics Market to forecast the revenues and analyze trends in each of the following sub-markets:
Type
Localized Autoimmune Disease Diagnostics
Addison Disease
Autoantibodies & Immunologic Test
Anti-cyclic Citrullinated Peptide
T3
Consumable & Assay Kit
Clinical Laboratory
Americas
Argentina
California
Australia
Denmark
The report offers valuable insights on the following aspects:
- Market Penetration: It presents comprehensive information on the market provided by key players.
- Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
- Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
- Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
- Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.
- What is the market size and forecast of the Autoimmune Disease Diagnostics Market?
- Which products, segments, applications, and areas should one consider investing in over the forecast period in the Autoimmune Disease Diagnostics Market?
- What are the technology trends and regulatory frameworks in the Autoimmune Disease Diagnostics Market?
- What is the market share of the leading vendors in the Autoimmune Disease Diagnostics Market?
- Which modes and strategic moves are suitable for entering the Autoimmune Disease Diagnostics Market?
Note: PDF & Excel + Online Access - 1 Year
- 1. Preface
- 1.1. Objectives of the Study
- 1.2. Market Segmentation & Coverage
- 1.3. Years Considered for the Study
- 1.4. Currency & Pricing
- 1.5. Language
- 1.6. Limitations
- 1.7. Assumptions
- 1.8. Stakeholders
- 2. Research Methodology
- 2.1. Define: Research Objective
- 2.2. Determine: Research Design
- 2.3. Prepare: Research Instrument
- 2.4. Collect: Data Source
- 2.5. Analyze: Data Interpretation
- 2.6. Formulate: Data Verification
- 2.7. Publish: Research Report
- 2.8. Repeat: Report Update
- 3. Executive Summary
- 4. Market Overview
- 4.1. Introduction
- 4.2. Autoimmune Disease Diagnostics Market, by Region
- 5. Market Insights
- 5.1. Market Dynamics
- 5.1.1. Drivers
- 5.1.1.1. Increasing Incidence of Autoimmune Diseases such as Rheumatoid Arthritis, Graves' disease and Hashimoto's thyroiditis
- 5.1.1.2. Awareness Among Public About Autoimmune Diseases and Favorable Government Initiatives
- 5.1.1.3. Improved Laboratory Techniques and Automation
- 5.1.2. Restraints
- 5.1.2.1. High Frequency of False Positive Results
- 5.1.2.2. Slow Turnaround Time for Diagnostic Test
- 5.1.3. Opportunities
- 5.1.3.1. Adoption of Biosensors for Autoimmune Disease Diagnosis
- 5.1.3.2. Strategic Partnerships Between Physicians and Clinical Laboratories
- 5.1.3.3. Potential Growth in Reagent Rental Agreements and Collaboration Activities
- 5.1.4. Challenges
- 5.1.4.1. Cost associated with the diagnosis process
- 5.2. Market Segmentation Analysis
- 5.3. Market Trend Analysis
- 5.4. Cumulative Impact of High Inflation
- 5.5. Porter’s Five Forces Analysis
- 5.5.1. Threat of New Entrants
- 5.5.2. Threat of Substitutes
- 5.5.3. Bargaining Power of Customers
- 5.5.4. Bargaining Power of Suppliers
- 5.5.5. Industry Rivalry
- 5.6. Value Chain & Critical Path Analysis
- 5.7. Regulatory Framework
- 6. Autoimmune Disease Diagnostics Market, by Type
- 6.1. Introduction
- 6.2. Localized Autoimmune Disease Diagnostics
- 6.3. Systemic Autoimmune Disease Diagnostics
- 7. Autoimmune Disease Diagnostics Market, by Indication
- 7.1. Introduction
- 7.2. Addison Disease
- 7.3. Celiac Disease
- 7.4. Dermatomyositis
- 7.5. Graves Disease
- 7.6. Hashimoto Thyroiditis
- 7.7. Multiple Sclerosis
- 7.8. Myasthenia Gravis
- 7.9. Pernicious Anemia
- 7.10. Reactive Arthritis
- 7.11. Rheumatoid Arthritis
- 7.12. Sjögren syndrome
- 7.13. Systemic Lupus Erythematosus
- 7.14. Type I Diabetes
- 8. Autoimmune Disease Diagnostics Market, by Test
- 8.1. Introduction
- 8.2. Autoantibodies & Immunologic Test
- 8.3.1. Anti-cyclic Citrullinated Peptide
- 8.3.2. Antinuclear Antibody
- 8.3.3. C-reactive Protein
- 8.3.4. Erythrocyte Sedimentation Rate
- 8.3.5. Rheumatoid Factor
- 8.3.6. Thyroid Antibody Tests
- 8.3.7.1. T3
- 8.3.7.2. T3RU
- 8.3.7.3. T4
- 8.3.7.4. TSH
- 8.3. Inflammatory Marker
- 8.4. Routine Laboratory Test
- 9. Autoimmune Disease Diagnostics Market, by Product
- 9.1. Introduction
- 9.2. Consumable & Assay Kit
- 9.3. Diagnostic Instrument
- 10. Autoimmune Disease Diagnostics Market, by End User
- 10.1. Introduction
- 10.2. Clinical Laboratory
- 10.3. Hospital
- 11. Americas Autoimmune Disease Diagnostics Market
- 11.1. Introduction
- 11.2. Argentina
- 11.3. Brazil
- 11.4. Canada
- 11.5. Mexico
- 11.6. United States
- 12. Asia-Pacific Autoimmune Disease Diagnostics Market
- 12.1. Introduction
- 12.2. Australia
- 12.3. China
- 12.4. India
- 12.5. Indonesia
- 12.6. Japan
- 12.7. Malaysia
- 12.8. Philippines
- 12.9. Singapore
- 12.10. South Korea
- 12.11. Taiwan
- 12.12. Thailand
- 12.13. Vietnam
- 13. Europe, Middle East & Africa Autoimmune Disease Diagnostics Market
- 13.1. Introduction
- 13.2. Denmark
- 13.3. Egypt
- 13.4. Finland
- 13.5. France
- 13.6. Germany
- 13.7. Israel
- 13.8. Italy
- 13.9. Netherlands
- 13.10. Nigeria
- 13.11. Norway
- 13.12. Poland
- 13.13. Qatar
- 13.14. Russia
- 13.15. Saudi Arabia
- 13.16. South Africa
- 13.17. Spain
- 13.18. Sweden
- 13.19. Switzerland
- 13.20. Turkey
- 13.21. United Arab Emirates
- 13.22. United Kingdom
- 14. Competitive Landscape
- 14.1. FPNV Positioning Matrix
- 14.2. Market Share Analysis, By Key Player
- 14.3. Competitive Scenario Analysis, By Key Player
- 15. Competitive Portfolio
- 15.1. Key Company Profiles
- 15.1.1. Abbott Laboratories
- 15.1.2. AESKU.GROUP GmbH & Co. KG
- 15.1.3. AstraZeneca PLC
- 15.1.4. Beckman Coulter, Inc.
- 15.1.5. Bio-Rad Laboratories, Inc.
- 15.1.6. BioAgilytix Labs
- 15.1.7. Biogenuix Medsystems Private Limited
- 15.1.8. bioMerieux SA
- 15.1.9. EUROIMMUN Medical Laboratory Diagnostics AG
- 15.1.10. Exagen Inc.
- 15.1.11. F. Hoffmann-La Roche AG
- 15.1.12. Hemagen Diagnostics, Inc.
- 15.1.13. Novartis AG
- 15.1.14. Pfizer Inc.
- 15.1.15. Quest Diagnostics
- 15.1.16. Sanofi S.A.
- 15.1.17. SD BioSensor Inc.
- 15.1.18. Siemens Healthineers AG
- 15.1.19. SQI Diagnostics
- 15.1.20. Thermo Fisher Scientific Inc.
- 15.1.21. Trinity Biotech PLC
- 15.1.22. Werfen Group
- 15.2. Key Product Portfolio
- 16. Appendix
- 16.1. Discussion Guide
- 16.2. License & Pricing
- FIGURE 1. AUTOIMMUNE DISEASE DIAGNOSTICS MARKET RESEARCH PROCESS
- FIGURE 2. AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, 2023 VS 2030
- FIGURE 3. AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, 2018-2030 (USD MILLION)
- FIGURE 4. AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY REGION, 2023 VS 2030 (%)
- FIGURE 5. AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 6. AUTOIMMUNE DISEASE DIAGNOSTICS MARKET DYNAMICS
- FIGURE 7. AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
- FIGURE 8. AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 9. AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY INDICATION, 2023 VS 2030 (%)
- FIGURE 10. AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY INDICATION, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 11. AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY TEST, 2023 VS 2030 (%)
- FIGURE 12. AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY TEST, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 13. AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
- FIGURE 14. AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 15. AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2023 VS 2030 (%)
- FIGURE 16. AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 17. AMERICAS AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
- FIGURE 18. AMERICAS AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 19. UNITED STATES AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
- FIGURE 20. UNITED STATES AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 21. ASIA-PACIFIC AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
- FIGURE 22. ASIA-PACIFIC AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 23. EUROPE, MIDDLE EAST & AFRICA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
- FIGURE 24. EUROPE, MIDDLE EAST & AFRICA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 25. AUTOIMMUNE DISEASE DIAGNOSTICS MARKET, FPNV POSITIONING MATRIX, 2023
- FIGURE 26. AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SHARE, BY KEY PLAYER, 2023
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook